Enlivex ENLV 深 滬
等待開盤 09-23 09:30:00 美东时间
0.6464
-0.046
-6.70%
華盛通- 最 高0.709
- 今 開0.69
- 成交量 123.43万股
- 最 低 0.5737
- 昨 收 0.6928
- 總市值 1130.26万
- 52周最高 27.15
- 市盈率 靜 0.00
- 換手率 7.06%
- 52周最低 0.5737
- 委 比 88.32%
- 總股本 1748.55万
- 歷史最高 673.50
- 量 比 2.54
- 振 幅 19.53%
- 歷史最低 0.5737
- 每 手 1
- 風險率 5.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enlivex shares are trading lower after the company announced the termination of its agreement to sell 66,666,667 shares to the Rain Foundation in exchange for RAIN tokens.
Enlivex shares are trading lower after the company announced the termination of its agreement to sell 66,666,667 shares to the Rain Foundation in exchange for RAIN tokens.
今天 01:08
Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement
An announcement from Enlivex ( ($ENLV) ) is now available. Enlivex Ltd., a Nasd...
09-22 20:27
Enliven’s Lead Drug Could Disrupt The Leukemia Treatment Market, Analyst Says
Enliven Therapeutics Inc. (NASDAQ:ELVN) drew an Outperform rating from William Blair on Tuesday as the firm initiated coverage, citing the potential for lead drug candidate ELVN-001 to reshape treatment of chronic myeloid leukemia (CML). ELVN-001 Shows Positive Phase 1 Data Enliven Therapeutics’ lea...
08-19 01:58
美股前瞻 | 美财长称明日与伊达成协议！道指、标普500指数期货齐创历史新高；光通信概念盘前飙升；SpaceX盘后放榜
美财长称明日与伊达成协议！道指、标普500指数期货齐创历史新高；光通信概念盘前飙升，Lumentum劲升13%；SpaceX盘后放榜！未来指引将“大于”业绩本身？>>
08-04 20:13
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Enlivex Announces Trading Volume On Rain Protocol Reaches $860M
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company powered by a prediction markets treasury, today provided an update on the Rain protocol trading metrics. Trading volume on the Rain protocol reached $860 million, and experienced a substantial increase of 622% betw...
07-30 20:05
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
Enlivex Ltd. will host a live webinar on July 30, 2026, at 10:00 AM ET to discuss its recent private placement, Rain protocol milestones, and clinical progress for Allocetra™, including its new FDA RMAT designation. The webinar will cover the rationale and value creation potential of the private placement, updates on the Rain protocol, and recent clinical advancements for Allocetra™ in treating knee osteoarthritis. Registration is available at [l...
07-29 12:00
Enlivex Secures $400 Million Premium-Priced Private Placement Backed by RAIN Tokens
Enlivex ( ($ENLV) ) just unveiled an update. On July 28, 2026, Enlivex announce...
07-28 20:27
Enlivex plunges in pre-market trade after announcing $400M private placement
Enlivex (ENLV) said on Tuesday that it intends to launch a private placement of $400M ordinary shares at a price of $5.00 per share for subscription amounts funded in U.S. dollars, USDT, or USD Coin a...
07-28 20:20
Enlivex shares are trading higher after the company announced its RAIN token holdings.
Enlivex shares are trading higher after the company announced its RAIN token holdings.
07-20 21:01
